|
AbrevaDrug - Abreva The trade name of the product as shown on the labeling.
Dosage -
CREAM; TOPICAL
Active Ingredient(s) -
Docosanol
Strength -
10%
Applicant -
GLAXOSMITHKLINE
New Drug Application (NDA) Number -
020941
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Jul 25, 2000
Reference Listed Drug (RLD) -
Yes
Type -
OTC
Applicant Full Name -
Glaxosmithkline
Abreva
Dobutamine Hcl In Dextrose 5% In Plastic Container Eq 400mg Base/100ml Injectable; Injection
Dobutamine Hcl In Dextrose 5% In Plastic Container Eq 50mg Base/100ml Injectable; Injection Dobutamine Hcl In Dextrose 5% In Plastic Container Eq 100mg Base/100ml Injectable; Injection Dobutamine Hcl In Dextrose 5% In Plastic Container Eq 200mg Base/100ml Injectable; Injection Dobutamine Hcl In Dextrose 5% In Plastic Container Eq 400mg Base/100ml Injectable; Injection Dobutamine Hcl In Dextrose 5% In Plastic Container Eq 50mg Base/100ml Injectable; Injection Dobutrex Eq 12.5mg Base/ml Injectable; Injection Taxotere Eq 40mg Base/ml Injectable; Injection Abreva 10% Cream; Topical Dobutamine Hcl In Dextrose 5% In Plastic Container Eq 200mg Base/100ml Injectable; Injection NewDrugInformation |